MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1246.3

Change

+11.91 (+0.96)%

Market Cap

N/A

Volume

0.03M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

+1.59 (+0.69%)

USD 165.08B
A Agilent Technologies Inc

+1.50 (+1.11%)

USD 40.09B
IQV IQVIA Holdings Inc

+0.88 (+0.44%)

USD 36.13B
LH Laboratory Corporation of Amer..

+1.65 (+0.72%)

USD 19.12B
DGX Quest Diagnostics Incorporated

+0.48 (+0.31%)

USD 17.09B
QGEN Qiagen NV

+0.24 (+0.54%)

USD 10.26B
CRL Charles River Laboratories

+0.90 (+0.49%)

USD 9.50B
VNRX Volitionrx Ltd

+0.04 (+6.56%)

USD 0.06B
ENZ Enzo Biochem Inc

-0.01 (-1.90%)

USD 0.04B
TMO Thermo Fisher Scientific Inc

+3.69 (+0.70%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

+0.07 (+0%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

N/A

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

N/A

N/A
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

+1.41 (+0%)

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+0.34 (+0%)

USD 6.91B
QRI:CA 0.00 % 1.06 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

+0.16 (+0%)

CAD 0.01B
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.75% 69% C- 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.75% 69% C- 34% F
Trailing 12 Months  
Capital Gain 2.22% 69% C- 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.22% 62% D 33% F
Trailing 5 Years  
Capital Gain 57.37% 58% F 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 57.37% 58% F 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 14.98% 100% F 75% C
Dividend Return 14.98% 100% F 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 29.73% 38% F 36% F
Risk Adjusted Return 50.37% 85% B 65% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.